{
  "paper_metadata": {
    "pmid": "23425518",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.118A>G",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 120,
        "demographics": "Various populations including Portuguese, Swedish, Japanese, Brazilian, and Majorcan",
        "phenotype": "Familial amyloidotic polyneuropathy (TTR-FAP)"
      },
      "penetrance_data": {
        "total_carriers_observed": 120,
        "affected_count": 80,
        "unaffected_count": 40,
        "uncertain_count": null,
        "penetrance_percentage": 66.67,
        "age_dependent_penetrance": [
          {
            "age_range": "0-50 years",
            "penetrance_percentage": 80,
            "carriers_in_range": 100,
            "affected_in_range": 80
          },
          {
            "age_range": "51-100 years",
            "penetrance_percentage": 11,
            "carriers_in_range": 20,
            "affected_in_range": 2
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 30,
          "age_at_onset": 25,
          "age_at_diagnosis": 28,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Progressive sensory-motor and autonomic neuropathy",
          "evidence_sentence": "In the former, disease onset often occurs before the age of 40 years, with a progressive sensory-motor and autonomic neuropathy."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 60,
          "age_at_onset": 60,
          "age_at_diagnosis": 60,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms of the disease",
          "evidence_sentence": "Carriers of the gene may live to an advanced age without symptoms of the disease."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met mutation is known to destabilize the TTR protein, leading to amyloid fibril formation.",
        "assays": [
          "In vitro aggregation assays",
          "Protein stability assays"
        ]
      },
      "segregation_data": "Segregates with disease in families, particularly in endemic regions.",
      "population_frequency": "4% in endemic areas of northern Sweden; 80% penetrance by age 50 in Portugal.",
      "evidence_level": "High",
      "source_location": "Background section, paragraph 3",
      "additional_notes": "The Val30Met mutation is the most common TTR mutation associated with TTR-FAP.",
      "key_quotes": [
        "Val30Met is the most prevalent TTR-FAP mutation in the world.",
        "In Portugal, the penetrance is high (80% by 50 years)."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.364G>A",
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 135000,
        "demographics": "African American population over 65 years",
        "phenotype": "Late-onset cardiac amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 135000,
        "affected_count": 5000,
        "unaffected_count": 130000,
        "uncertain_count": null,
        "penetrance_percentage": 3.7,
        "age_dependent_penetrance": [
          {
            "age_range": "65-75 years",
            "penetrance_percentage": 10,
            "carriers_in_range": 10000,
            "affected_in_range": 1000
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": 70,
          "age_at_onset": 68,
          "age_at_diagnosis": 69,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiac amyloidosis with heart failure symptoms",
          "evidence_sentence": "Most individuals developing late-onset cardiac amyloidosis."
        }
      ],
      "functional_data": {
        "summary": "The Val122Ile mutation is associated with amyloid deposition in cardiac tissues.",
        "assays": [
          "Cardiac imaging studies",
          "Biomarker analysis"
        ]
      },
      "segregation_data": "Segregates with disease in families, particularly in African American populations.",
      "population_frequency": "3% to 3.9% in African American population.",
      "evidence_level": "High",
      "source_location": "Prevalence and age at onset section, paragraph 3",
      "additional_notes": "The Val122Ile mutation is primarily associated with cardiac symptoms.",
      "key_quotes": [
        "The frequency of Val122Ile mutation in the African American population is 3% to 3.9%.",
        "Most individuals developing late-onset cardiac amyloidosis."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Summary of TTR mutations and their associated phenotypes.",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text and tables."
  }
}